LBA-1 Phase 3 APACT trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P + Gem) vs gemcitabine (Gem) alone in patients with resected pancreatic cancer (PC): Updated 5-year overall survival

Margaret A. Tempero, Eileen M. O’Reilly, Eric Van Cutsem, Jordan Berlin, P. A. Philip, David Goldstein, Josep Tabernero, Mitesh J. Borad, J-B. Bachet, Vibeke K. Parner, Niall C. Tebbutt, Yu Chua, Pippa Corrie, Marion Harris, Julien Taı̈eb, Matthew Burge, Volker Kunzmann, G. Zhang, D. McGovern, Helen Margaret Marks, Andrew V. Biankin, Michele Reni